Evidence map›Paper›PMID 38380034›Full record

ArticleHeliyon2024

Genetic characteristics of SARS-CoV-2 virus variants observed upon three waves of the COVID-19 pandemic in Ukraine between February 2021-January 2022.

Ganna V Gerashchenko, Nataliya V Hryshchenko, Nataliia S Melnichuk, Tetiana V Marchyshak, Serhii Yu Chernushyn, Irina V Demchyshina, Ludmyla M Chernenko, Igor V Kuzin, Zenovii Yu Tkachuk, Vladimir I Kashuba and 1 more

Open access · goldAbstract read
In one paragraph

Article in Heliyon, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
2.3field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 6 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 2 institutions in 1 country.

Ganna V GerashchenkoInstitute of Molecular Biology and Genetics of NAS of Ukraine, Kyiv, Ukraine.
Nataliya V HryshchenkoInstitute of Molecular Biology and Genetics of NAS of Ukraine, Kyiv, Ukraine.
Nataliia S MelnichukInstitute of Molecular Biology and Genetics of NAS of Ukraine, Kyiv, Ukraine.
Tetiana V MarchyshakInstitute of Molecular Biology and Genetics of NAS of Ukraine, Kyiv, Ukraine.
Serhii Yu ChernushynInstitute of Molecular Biology and Genetics of NAS of Ukraine, Kyiv, Ukraine.
Irina V DemchyshinaPublic Health Center of the Ministry of Health of Ukraine, Kyiv, Ukraine.
Ludmyla M ChernenkoPublic Health Center of the Ministry of Health of Ukraine, Kyiv, Ukraine.
Igor V KuzinMinistry of Health of Ukraine, Kyiv, Ukraine.
Zenovii Yu TkachukInstitute of Molecular Biology and Genetics of NAS of Ukraine, Kyiv, Ukraine.
Vladimir I KashubaInstitute of Molecular Biology and Genetics of NAS of Ukraine, Kyiv, Ukraine.
Mykhailo A TukaloInstitute of Molecular Biology and Genetics of NAS of Ukraine, Kyiv, Ukraine.
Institute of Molecular Biology and Genetics · UAMinistry of Health · UA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The aim: of our study was to identify and characterize the SARS-CoV-2 variants in COVID-19 patients' samples collected from different regions of Ukraine to determine the relationship between SARS-CoV-2 phylogenetics and COVID-19 epidemiology. Patients and methods: Samples were collected from COVID-19 patients during 2021 and the beginning of 2022 (401 patients). The SARS-CoV-2 genotyping was performed by parallel whole genome sequencing. Results: The obtained SARS-CoV-2 genotypes showed that three waves of the COVID-19 pandemic in Ukraine were represented by three main variants of concern (VOC), named Alpha, Delta and Omicron; each VOC successfully replaced the earlier variant. The VOC Alpha strain was presented by one B.1.1.7 lineage, while VOC Delta showed a spectrum of 25 lineages that had different prevalence in 19 investigated regions of Ukraine. The VOC Omicron in the first half of the pandemic was represented by 13 lines that belonged to two different clades representing B.1 and B.2 Omicron strains. Each of the three epidemic waves (VOC Alpha, Delta, and Omicron) demonstrated their own course of disease, associated with genetic changes in the SARS-CoV-2 genome. The observed epidemiological features are associated with the genetic characteristics of the different VOCs, such as point mutations, deletions and insertions in the viral genome. A phylogenetic and transmission analysis showed the different mutation rates; there were multiple virus sources with a limited distribution between regions. Conclusions: The evolution of SARS-CoV-2 virus and high levels of morbidity due to COVID-19 are still registered in the world. Observed multiple virus sourses with the limited distribution between regions indicates the high efficiency of the anti-epidemic policy pursued by the Ministry of Health of Ukraine to prevent the spread of the epidemic, despite the low level of vaccination of the Ukrainian population.

Indexed as

COVID-19DeltaNGSOmicronSARS-CoV-2 genotypingVOC Alpha

Identifiers

PMID38380034
PMCPMC10877268
OpenAlexW4391597904

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.